HIVEP3 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with HIVEP3 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with HIVEP3 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with HIVEP3 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with HIVEP3 Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000131143 - cytochrome c oxidase subunit 4I1

Gene

ENSG00000123685 - basic leucine zipper ATF-like transcription factor 3

Gene

ENSG00000148985 - post-GPI attachment to proteins 2

Gene

ENSG00000214026 - mitochondrial ribosomal protein L23

Gene

ENSG00000213366 - glutathione S-transferase mu 2

Gene

ENSG00000068001 - hyaluronidase 2

Gene

ENSG00000167759 - kallikrein related peptidase 13

Gene

ENSG00000142507 - proteasome 20S subunit beta 6

  • Gene

    ENSG00000131143 - cytochrome c oxidase subunit 4I1


  • Gene

    ENSG00000123685 - basic leucine zipper ATF-like transcription factor 3


  • Gene

    ENSG00000148985 - post-GPI attachment to proteins 2


  • Gene

    ENSG00000214026 - mitochondrial ribosomal protein L23


  • Gene

    ENSG00000213366 - glutathione S-transferase mu 2


  • Gene

    ENSG00000068001 - hyaluronidase 2


  • Gene

    ENSG00000167759 - kallikrein related peptidase 13


  • Gene

    ENSG00000142507 - proteasome 20S subunit beta 6

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.